Fundraising FoxNf2Tx
Cambridge, US · 1 known investors
Find your way into Nf2Tx
Sign up to find every way you can get introduced to Nf2Tx
- Your email: who you already know at Nf2Tx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nf2Tx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
Founders & leadership
MW
Michael WoottonCo-Founder & CEO
MD
Mark de SouzaCo-Founder
SP
Scott PlotkinCo-Founder
Board
MG
Marco Giovannini
Investors · 1
Frequently asked questions
- What does Nf2Tx do?
- NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
- Who founded Nf2Tx?
- Nf2Tx was founded by Michael Wootton, Mark de Souza, Scott Plotkin.
- Who are Nf2Tx's investors?
- Nf2Tx's investors include Beacon Angels.
- Where is Nf2Tx headquartered?
- Nf2Tx is headquartered in Cambridge, US.